245 filings
8-K
APDN
Applied Dna Sciences Inc
29 May 24
Applied DNA Announces Pricing of $12 Million Public Offering
4:33pm
8-K
APDN
Applied Dna Sciences Inc
16 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:25pm
8-K
APDN
Applied Dna Sciences Inc
10 May 24
Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results
4:07pm
8-K
APDN
Applied Dna Sciences Inc
1 May 24
Regulation FD Disclosure
9:28am
8-K/A
APDN
Applied Dna Sciences Inc
23 Apr 24
Amendments to Articles of Incorporation or Bylaws
2:45pm
8-K
w2u hvbov
22 Apr 24
Applied DNA Announces 1-For-20 Reverse Stock Split
5:00pm
8-K
0nako3m
19 Apr 24
Entry into a Material Definitive Agreement
4:15pm
8-K
opqlhwaxc74mlx
16 Apr 24
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
zq4xd1zshdwve7zuw bh
8 Feb 24
Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
4:05pm
8-K
zy9r0ryb jrlyua56fq2
1 Feb 24
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
12:00am
8-K
ty3ag3yjd 808eh
30 Jan 24
Termination of a Material Definitive Agreement
9:21pm
8-K
qlef38c1op
8 Jan 24
Regulation FD Disclosure
7:00am
8-K
t0o9q
5 Jan 24
Departure of Directors or Certain Officers
4:30pm
8-K
kh99zk4
7 Dec 23
Applied DNA Announces Fourth Quarter Fiscal Year 2023
4:05pm
8-K
vtc0a0
6 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
jlleoga1
7 Nov 23
Entry into a Material Definitive Agreement
5:09pm
8-K
yyhev
20 Sep 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
i90od33n5fmasfjr1
10 Aug 23
Applied DNA Reports Third Quarter Fiscal 2023 Financial Results and Provides Corporate Update
4:05pm
8-K
ik1ap
1 Aug 23
Departure of Directors or Certain Officers
4:02pm
8-K
vee7a7277788dc
13 Jul 23
Entry into a Material Definitive Agreement
5:04pm